LINKBANCORP, Inc. (LNKB)

Revance Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest Income on Loans	147.01	146.18	58.79	36.4	15.92	11.49
Interest Income on Investments	12.96	12.55	6.41	3.87	2.57	2.8
Total Interest Income	159.97	158.72	65.2	40.26	18.5	14.29
Interest Paid on Deposits	50.94	51.03	22.64	5.34	2.09	2.66
Interest Paid on Borrowings	7.72	7.8	3.85	1.94	0.3	0.06
Total Interest Expense	58.66	58.83	26.49	7.28	2.39	2.72
Net Interest Income	101.31	99.89	38.71	32.99	16.11	11.57
Net Interest Income Growth (YoY)	40.63%	158.05%	17.36%	104.80%	39.16%	-1.95%
Gain (Loss) on Sale of Investments	-	0	-2.37	0.01	0.07	0.11
Other Non-Interest Income	5.45	4.55	2.01	1.36	1.02	0.54
Total Non-Interest Income	21.47	8.86	1.09	2.96	2.14	1.75
Non-Interest Income Growth (YoY)	280.52%	715.27%	-63.24%	38.24%	21.95%	50.82%
Revenues Before Loan Losses	122.77	108.76	39.8	35.94	18.25	13.33
Provision for Loan Losses	0.79	0.26	9.3	1.29	0.65	0.18
Revenue	121.98	108.5	30.5	34.65	17.6	13.14
Revenue Growth (YoY)	79.01%	255.70%	-11.97%	96.92%	33.88%	4.72%
Salaries and Employee Benefits	39.73	39.38	19.65	15.7	6.76	4.54
Federal Deposit Insurance	2.64	2.4	0.82	0.64	0.23	0.07
Amortization of Goodwill & Intangibles	4.53	4.78	0.66	-	-	-
Selling, General & Administrative	17.87	18.26	9.72	6.93	3.27	2.17
Other Non-Interest Expense	9.43	9.17	3.8	3.59	2.65	1.52
Total Non-Interest Expense	74.19	73.99	34.66	26.86	12.91	8.31
EBT Excluding Unusual Items	47.79	34.51	-4.15	7.79	4.68	4.84
Pretax Income	47.51	33.6	-15.33	6.82	0.1	4.84
Income Tax Expense	10.1	7.39	-3.36	1.22	-0.19	0.65
Net Income	37.41	26.21	-11.97	5.6	0.29	4.19
Net Income to Common	37.41	26.21	-11.97	5.6	0.29	4.19
Net Income Growth	-	-	-	1837.02%	-93.11%	4.67%
Basic Shares Outstanding	37	37	18	11	7	6
Diluted Shares Outstanding	37	37	18	11	7	6
Shares Change (YoY)	31.41%	109.00%	56.97%	55.99%	27.39%	631.33%
EPS (Basic)	1.01	0.71	-0.67	0.49	0.04	0.74
EPS (Diluted)	1.01	0.71	-0.67	0.49	0.04	0.74
EPS Growth	-	-	-	1125.00%	-94.57%	-85.69%
Dividend Per Share	0.300	0.300	0.300	0.300	0.205	1.300
Dividend Growth	-	-	-	46.34%	-84.23%	-16.13%
Effective Tax Rate	21.25%	21.98%	-	17.92%	-	13.33%

Updated May 9, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q